Tag: multiparametric MRI

Today’s multiparametric MRI (mpMRI) is better than ever. When a patient’s PSA blood test raises suspicion of prostate cancer (PCa), mpMRI determines if a targeted biopsy is needed. It does this by making significant lesions visible prior to an invasive biopsy. Significant means Gleason 3+4 or greater, also characterized as Grade Group 2 or greater. keep reading

Okay, folks, this is BIG NEWS! A research study out of the esteemed Johns Hopkins University School of Medicine and two other academic centers may be the first of its kind to definitively connect healthy diet with reining in prostate cancer (PCa). Specifically, the study population was done with PCa patients currently on Active Surveillance keep reading

If you’re a real estate developer planning to build a new house, you start with the groundwork—literally. Before you start excavating, you have analysts determine the basics: the type of soil, the water table, and any flood risk. You want to know the important foundation factors that help predict the future stability of the construction. keep reading

Radiation for prostate cancer can come with long-term sexual side effects that aren’t always discussed upfront. While erectile dysfunction is well known, new research highlights issues with ejaculation, including reduced volume and discomfort. Patients deserve full transparency about these risks before choosing treatment. Learn why informed decision-making is crucial. keep reading

In the world of prostate cancer (PCa), there is a dangerous cell pattern called cribriform (pronounced crib’ ri-form) or simply Cr. It has a distinctive appearance that looks similar to a sieve or a plate with lots of holes. Cr is associated with aggressive Gleason grade 4 cancer. Also, there is another PCa type called keep reading

New research reveals that liquid biomarkers—measured through simple blood and urine tests—are revolutionizing prostate cancer care. By detecting disease progression early, they help prevent overtreatment and ensure timely, targeted therapies for metastatic cases. Discover how these cutting-edge tests are reshaping prostate cancer care. keep reading

We’ve posted numerous blogs on the contributions of Artificial Intelligence (AI) to various aspects of MRI detection and diagnosis of prostate cancer (PCa). We’ve reported AI’s ability to predict metastasis, assign Gleason scores and PI-RADS scores, pinpoint tumor margins for focal therapy, rule out need for biopsy, predict PCa metastasis, and more—showing the accuracy and keep reading

If you’ve ever been involved in a simulation game, or a simulation training model, you are interacting with something that’s not really there but feels like it is. In fact, during the experience the same neurons in the brain are activated as if the simulation IS the real world. Thus, the brain can be functionally keep reading

Active Surveillance for prostate cancer is a life-saving option but often comes with a heavy emotional toll. Learn how managing anxiety and uncertainty can transform your journey. Explore why psychological tools and innovative treatments, like MRI-guided focal laser ablation, are reshaping the experience for patients worldwide. keep reading

Want to avoid a biopsy after an abnormal PSA test? A new study shows that a negative multiparametric MRI might just be your ticket. Learn how MRI scans are reducing unnecessary biopsies and pinpointing significant prostate cancer with precision. keep reading